Tanzania is preparing to introduce a specialised medication for treating alcohol addiction in public hospitals, marking a shift toward expanding mental health and substance abuse services nationwide.
Health authorities say the drug—already used in other countries to support recovery from alcohol dependence—will be integrated into public healthcare facilities to improve access to treatment for patients struggling with addiction. The move is part of broader efforts to strengthen the country’s response to substance abuse and related health challenges.
Officials note that alcohol misuse remains a growing concern, contributing to a range of health and social problems, including injuries, mental health disorders, and chronic diseases. Expanding treatment options is seen as critical in addressing these risks and improving overall public health outcomes.
The rollout will be supported by training for healthcare workers to ensure proper diagnosis, prescription, and monitoring of patients undergoing treatment. Authorities say building capacity within the health system is essential to ensure the programme’s effectiveness.
The initiative also aligns with ongoing efforts to integrate mental health services into primary healthcare, making treatment more accessible, especially in underserved areas. Experts have previously highlighted limited resources and treatment options as key gaps in addressing alcohol use disorders in Tanzania.
In addition to medication, the programme is expected to include counselling and behavioural support, providing a more comprehensive approach to recovery. This reflects a growing recognition that effective treatment of addiction requires both medical and psychosocial interventions.
Officials say the introduction of the drug represents a significant step in improving care for people affected by alcohol addiction, while also helping reduce the broader social and economic impact associated with substance abuse.
